Financial PerformanceOmnicell's long-term targeted financial algorithm is favorable at a mid-teens revenue growth rate and roughly 400bps of annual margin expansion from 2021 equating to high-teens compounding EBITDA growth.
Market StrategyOmnicell noted that since the announcement of an upcoming Pyxis refresh, Omnicell has won new clients which it believes speaks to the quality of its product and clients' confidence in Omnicell.
Product And ServicesAmplify's Careplus subscription service is credited with helping avoid stockouts and improve inventory management including controlled substances.